What INR is safe for a spinal or epidural?

There isn't one number, and the number most people quote is for the wrong thing. 1.5 is the catheter removal threshold. For needle placement, ASRA gives no number at all — it says normalized.

Reviewed and updated September 2026 · Written by Anastasia Jackson, DNAP, CRNA

Every clinical claim on this page is cited to its source below. How we source clinical content — and the corrections we have made, with what each one was and why it changed.

Ask five clinicians what INR is safe for a spinal and most will say 1.5. That number is in the guideline, but it attaches to removing an epidural catheter, not to putting a needle in. The placement standard is written differently, and the gap between the two is where nearly all of the confusion in this topic lives.

What the guideline actually says

The current source is the fifth edition of the ASRA evidence-based guidelines, published in January 2025, which reviews evidence since 2018 and supersedes the fourth edition.¹

Note what the placement row does not contain. There is no 1.4, no 1.5, no threshold of any kind. The standard is the local laboratory's reference range, which is why two hospitals can hold different numbers and both be compliant. The joint European guidance takes the same approach, and the fifth edition ASRA terminology was deliberately aligned toward it.⁸

Why "normalized" rather than a number

Warfarin — Coumadin — inhibits synthesis of the vitamin K-dependent clotting factors II, VII, IX and X. The INR is not a measure of all four. It is dominated by factor VII, which has the shortest half-life of the group at roughly 6 hours.

The guideline states the consequence plainly: adequate levels of factors II, VII, IX and X may not be present until the INR is within normal limits.^1,2 A partially corrected INR tells you that factor VII has come back. It does not tell you about factor II, whose half-life runs 60 to 72 hours, or factor X at 24 to 48 hours.

This is the whole reason the standard is written as "normalized" instead of as a number. A number invites the reader to treat the INR as a direct readout of hemostatic competence, which for a patient on warfarin it is not.

The 1-to-3-day trap

This is the single most useful thing to carry out of this page, because it is the situation you will actually meet: the patient whose warfarin was held two days ago for a procedure, whose INR has drifted down to 1.3 or 1.4, and whose chart looks reassuring. Five days is the interval in the guideline for a reason.

The same logic runs in reverse at the other end of the admission. When warfarin is being started for thromboprophylaxis, an early INR rise also reflects factor VII, and factors II and X remain adequate for a period — which is why the guideline observes that catheter removal within the first 48 hours of warfarin initiation is a different proposition from removal after several days of therapy.²

Two things that complicate the removal number

The 1.5 threshold is probably conservative

A prospective and retrospective observational series enrolled 4,365 total joint replacement patients on daily warfarin thromboprophylaxis and reported uncomplicated removal of epidural catheters at an INR greater than 1.4.³ All patients had normal coagulation testing before surgery, and all nonsteroidal anti-inflammatory drugs and anticoagulants were held preoperatively. The authors framed the existing guidance as possibly too conservative.

The guideline text also cites a separate series of 11,235 patients receiving epidural analgesia after total knee replacement with warfarin started the night of surgery and catheters removed within 48 hours. In a subset of 1,030 patients the mean INR at removal was 1.5, with a range of 0.9 to 4.3, and the INR was below 1.5 in fewer than half of them. There were no spinal hematomas.²

Not every elevated INR is a warfarin INR

An INR elevated by liver disease, malnutrition, or vitamin K deficiency does not carry the same bleeding implication as an equivalent number produced by therapeutic vitamin K antagonism. The guideline was written around warfarin specifically. In cirrhosis in particular, the INR rises because synthetic function is impaired across procoagulant and anticoagulant factors — protein C and protein S fall alongside the others — so the number overstates bleeding risk relative to what it means in an anticoagulated patient.

That is not a reason to proceed. It is a reason to recognize that you are outside the evidence base the guideline was built on, and that hematology input and viscoelastic testing may tell you more than the INR does.

What ASRA does not distinguish

The guideline draws no separate line between a single-shot spinal with a 25-gauge pencil-point needle and an indwelling epidural catheter, even though the hematoma risk is not intuitively the same. A single dural puncture with a small non-cutting needle and a catheter sitting in the epidural space for two days across a period of changing anticoagulation are different exposures.

The guideline does not make that allowance, and the honest statement is that it does not draw the line rather than that the line does not exist. The reason is structural: spinal hematoma is rare enough that no dataset separates these techniques with any power. Where the fifth edition does apply the same standard across procedures, it does so explicitly — the same intervals govern neuraxial blocks and deep plexus or deep peripheral blocks alike.¹

When the INR is not normalized

If the procedure is elective, the answer is to wait. Where it is not, these are the levers, and none of them are the anesthesia clinician's decision alone.

Frequently asked questions

What INR is safe for a spinal or epidural?

For needle placement, ASRA does not give a number. It recommends stopping the anticoagulant 5 days before the procedure and confirming the INR is measured and normalized to the local laboratory's normal range before placement, a Grade 1B recommendation.¹ Depending on the laboratory that is roughly 1.2 or below, and NYSORA reads the ASRA position as effectively 1.1 or below.⁷ The commonly quoted 1.5 is the epidural catheter removal threshold, not the placement standard.

Is an INR of 1.5 safe for placing a spinal?

That number applies to catheter removal, not placement. ASRA suggests removing neuraxial catheters when the INR is less than 1.5, a Grade 2C suggestion, with neurologic assessment continued at least 24 hours afterward.¹ The basis is that an INR of 1.5 corresponds to clotting factor activity above 40%, which is associated with normal hemostasis. For placement the standard is a normalized INR.

Can I do a neuraxial block if the INR is 1.4 two days after warfarin was stopped?

That specific scenario is the one ASRA flags. In the first 1 to 3 days after chronic warfarin is stopped, the INR falls because factor VII recovers first, while factors II and X may still be inadequate for hemostasis — so coagulation status may not be adequate despite a decreasing INR.^1,2 An INR of 1.4 on day 2 off warfarin is not equivalent to an INR of 1.4 in a patient who was never anticoagulated.

How long before a spinal should warfarin be held?

Five days, with the INR measured and normalized before needle placement.¹ If a first dose of warfarin was given preoperatively, ASRA suggests checking the INR before placement when that dose was given more than 24 hours earlier, or when a second dose has been administered.

What is the INR cutoff for removing an epidural catheter?

Less than 1.5, with neurologic assessment continued at least 24 hours after removal.¹ If the INR is above 3 with a catheter in place, the warfarin dose should be held or reduced (Grade 1A). Between 1.5 and 3, catheters may be maintained or removed with caution based on the INR and the duration of warfarin therapy.

Does an elevated INR from liver disease carry the same risk?

Not necessarily. The guideline was written around vitamin K antagonism. In liver disease the INR rises because synthetic function falls across procoagulant and anticoagulant factors together, so the number does not map onto bleeding risk the way a warfarin INR does. This puts you outside the evidence base rather than inside a safer version of it, and it is a situation for hematology input and viscoelastic testing rather than for applying the warfarin thresholds.

Is there a different INR threshold for a single-shot spinal than for an epidural catheter?

ASRA does not draw one. The same standard applies to both, even though a 25-gauge pencil-point needle and an indwelling catheter are not the same hematoma exposure. Spinal hematoma is too rare for any dataset to separate the techniques with statistical power, so the guideline declines to make the distinction rather than making one that the evidence cannot support.

References

1. Kopp SL, Vandermeulen E, McBane RD, Perlas A, Leffert L, Horlocker T. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition). Reg Anesth Pain Med. Published online 29 January 2025. doi:10.1136/rapm-2024-105766. PMID 39880411.
2. Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fourth edition). Reg Anesth Pain Med. 2018;43(3):263–309. Source of the factor II and X caution, the 11,235-patient total knee replacement series, and the observation on catheter removal within the first 48 hours of warfarin initiation.
3. Liu SS, Buvanendran A, Viscusi ER, Hutton E, Lubenow T, Zhou J, Shaw PM, Moric M, Lenart S. Uncomplicated removal of epidural catheters in 4365 patients with international normalized ratio greater than 1.4 during initiation of warfarin therapy. Reg Anesth Pain Med. 2011;36(3):231–235. PMID 21451439.
4. Mulroy MF, Neal JM. Epidural catheter removal in patients on warfarin thromboprophylaxis: a more cautious interpretation of results required? Reg Anesth Pain Med. 2011;36(3):209–210. doi:10.1097/AAP.0b013e3182183583. PMID 21508790.
5. Carvalho B, Mariano ER, Butwick AJ. Epidural catheter removal in patients on warfarin thromboprophylaxis. Reg Anesth Pain Med. 2011. PMID 22024706.
6. Horlocker TT, Heit JA, Wedel DJ, Enneking FK, Rowlingson JC. Safe epidural catheter removal in the patient receiving warfarin: does anybody really know what (prothrombin) time it is? Anesthesiology. 2010;113(3):759–761. doi:10.1097/ALN.0b013e3181ec644a. PMID 20733402.
7. NYSORA. Regional anesthesia in anticoagulated patients. Source of the reading that the ASRA position on warfarin corresponds to an INR of 1.1 or below, of the catheter removal threshold with 24-hour neurologic observation, and of vitamin K reversal in the absence of major bleeding.
8. Kietaibl S, Ferrandis R, Godier A, et al. Regional anaesthesia in patients on antithrombotic drugs: joint ESAIC/ESRA guidelines. Eur J Anaesthesiol. 2022. The European counterpart, which the fifth edition ASRA terminology was aligned toward.